• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, June 24, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Missed health checks for type 2 diabetes costing Australia billions

by rhiannon bowman
July 19, 2023
in Diabetic eye disease, Eye disease, Local, News, Ophthalmic insights, Research
Reading Time: 4 mins read
A A
Missed health checks contribute to the increased prevalence of diabetes-related hospitalisations and complications.

Missed health checks contribute to the increased prevalence of diabetes-related hospitalisations and complications.

Share on FacebookShare on Twitter

Missed health checks – including eye examinations – reduced access to routine healthcare for people living with type 2 diabetes could be costing the Australian health system around $2.3 billion per annum, according to Diabetes Australia.

New modelling, based on US research, found that the cost impact of people in Australia living with type 2 diabetes not receiving recommended care was around AU$3,564 per person per annum.

Taryn Black, Diabetes Australia.

An estimated 50% of Australians living with type 2 diabetes are not accessing a range of recommended diabetes health checks that help to prevent and manage diabetes-related complications including checks for diabetes management, cholesterol, kidneys, feet and eye health.

Missed health checks contribute to the increased prevalence of diabetes-related hospitalisations and complications. Annually this includes:

  • 100,000 hospitalisations for eye complications
  • 710,000 admissions to hospital for dialysis
  • 256,000 admissions to hospital for other kidney-related conditions
  • 19,000 diabetes-related emergency admissions
  • 5,163 amputations

This results in extra costs to the health system, with an increased prevalence of diabetes-related complications, many of which are preventable, Diabetes Australia stated.

Ms Taryn Black, director of the KeepSight diabetes eye check reminder program, said in addition to the impact of missed eye health checks on the economy, it was also a significant, but unnecessary, risk for the individual.

“We know that regular eye checks and early intervention can prevent more than 90% of vision loss for people with diabetes. Quite simply, regular checks save sight,” Black said.

KeepSight was developed specifically to address this issue by sending people reminders when they are due for an eye check.

Run by Diabetes Australia and now in its fourth year, the program’s goal is to ensure all Australians with diabetes are receiving regular eye checks. It’s backed by a public/private partnership with the Federal Government and Specsavers.

Diabetes Australia Group CEO Ms Justine Cain said diabetes was complex and could lead to a range of debilitating and costly complications, many that could be prevented or delayed by ensuring people receive timely and appropriate medical care.

“One of the challenges with Australia’s healthcare system is that it has been orientated towards treating people when they are sick and unwell, rather than preventing issues before they develop,” Cain said.

“For people with diabetes, this means we need to ensure people can easily access the routine health checks which can detect problems like vision loss early when it is most treatable.

“That’s why we are strong supporters of the Federal Government’s Strengthening Medicare process which will create a health system that better meets the needs of people living with chronic conditions such as diabetes.”

On the back of National Diabetes Week in July, Diabetes Australia is currently working with people living with diabetes to document their experience to inform the Australian Government’s Parliamentary Inquiry into Diabetes.

“We’re hoping to amplify the voice of people with diabetes who understand the reality of living with diabetes better than anyone to ensure this inquiry focusses on the priorities that will change the future,” Cain said.

“We need to have a health system that is geared towards supporting people living with diabetes to live well and prevent diabetes-related complications and protect our health system.”

Mr Linden Moffatt knows this only too well. As part of his diabetes management he receives KeepSight reminders and regularly sees an optometrist.

“I know many individuals who have been affected by diabetes related eye disease and I’ve witnessed first-hand the effect these conditions have on their lives, their confidence. I encourage everyone to have their eyes monitored and tested. An early detection can be the difference between keeping and losing your vision,” Moffatt said.

More reading

Undiagnosed and unmanaged diabetes focus of National Diabetes Week

KeepSight’s targeted approach increases uptake of diabetes eye checks

New Diabetes Australia report reveals dramatic jump in diabetes costs for economy

Related Posts

The CureSight device trains the visual system to use both eyes simultaneously, while the user watches any streamed video content of choice through treatment glasses. Image: BOC Instruments.

CureSight – eye-tracking amblyopia treatment for use at home

by Staff Writer
June 24, 2025

BOC Instruments has announced the launch of a new technology that leverages proprietary eye-tracking technology and cloud-based remote monitoring to...

With support from The Fred Hollows Foundation, Chanthoeun from Cambodia received a pair of special prescription glasses to help with her high myopia and she now conducts basic eyesight tests for her children using skills she learned at the vision centre. Image: Michael Amendolia.

Lancet: Glasses still out of reach for millions of people

by Staff Writer
June 24, 2025

New data released in The Lancet Global Health by the Vision Loss Expert Group and World Health Organisation (WHO) and supported by...

Tokai says its ophthalmic coatings deliver superior scratch resistance, clarity, and durability. Image: Tokai.

Tokai – proving to be the quiet disruptor in Aussie sector

by Staff Writer
June 23, 2025

With its commitment to the quality of light, lenses and life, plus its different approach to lens supply, Japanese optical...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited